New stent aims to unclog leg arteries safely

NCT ID NCT07010354

Recruiting now Disease control Sponsor: Bentley InnoMed GmbH Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 17, 2026 · Updated 2 times

Summary

This study is testing a covered stent called BeFlow to treat narrowed or blocked iliac arteries in the pelvis. Researchers will monitor 100 patients to see how well the stent restores blood flow and how safe it is. The goal is to improve walking ability and reduce pain caused by poor circulation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: BeFlow iliac covered stent
What this could lead to: If successful, this stent could offer a reliable option to restore blood flow in blocked iliac arteries, reducing symptoms like leg pain and improving mobility.
What could go wrong: This is an observational study, not a randomized trial, so results may be less definitive. Risks include stent-related complications like re-blockage or blood clots.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ILIAC ARTERY OCCLUSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

arterial occlusion

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ILIAC ARTERY OCCLUSION ILIAC ARTERY STENOSIS

Contacts and locations

Locations

AZ Sint Blasius
RECRUITING

Dendermonde, 9200, Belgium
AZORG
RECRUITING

Aalst, 9300, Belgium
CHU de Liège
RECRUITING

Liège, 4000, Belgium
EOC - Ente Ospedaliero Cantonale
RECRUITING

Lugano, Canton Ticino, 6900, Switzerland
Ziekenhuis Oost-Limburg AV
RECRUITING

Genk, 3600, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.